Dr. Stephen Klein
speaker
550 appearances
1 recordings
1 series
first heard Jun 2026
last heard 25 Jun
Dr. Stephen Klein’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jun 2026 with 1.
Appearances
So that's a public health initiative that we see things like now naloxone, the nasal sprays, really stopping people from having severely negative consequences from their use.
I think as far as abstinence, it depends on whose definition of abstinence we're using, because some of the medications that we'll talk about have a stigma of people not being abstinent because they are, in fact, other forms of opioids.
So that
That can be a little challenging, but I would say overall the goal is to first reduce morbidity and mortality.
Secondly, allow people to start reengaging with their lives, with their community, with their work so that they can have some agency back in their decision making.
So agency for me is the ability to make decisions that align with your value system, not the value system of medicine, not the value system of a corporation, not the value system of any marketing, but really your value system.
I think when we talk about addiction, it's a real loss of agency.
So you're no longer making decisions based on your values.
You're making decisions based on the need.
With opioids, the need is real.
Withdrawing from opioids is very painful, very uncomfortable.
A lot of patients at the end of their addiction are using just to maintain the feeling of normalcy and avoid withdrawal.
That's not a place that aligns with many people's value systems.
Unfortunately, those two that you mentioned are incredibly hard to measure.
So now we really get into, in my mind, where I think about the treatment of addiction and the real instillment of recovery.
Those are not always synonymous.
I think for addiction, we have measures like morbidity, mortality.
Those outcome measures are going to be decreasing overdose, retention in treatment, things like that.
For those, we have really effective interventions, and we can measure those because we have somewhat simple outcomes.
Very important, but very simple.
Showing 81–100 of 550 · page 5 of 28
← Previous
Next →